This research investigates the hypothesis that publicly funded scientific research complements private R&D investment in the pharmaceutical industry. New microlevel data on public research investment by the U.S. National Institutes of Health allow measures of basic and clinical research in seven...

Using a reduced form binary econometric model, we analyze the determinants of pharmaceutical companies entry decisions into new submarkets. Our sample includes data for pharmaceutical companies over the period 1987-1998 for seven countries. Estimation is done both at the aggregate level and at a...

In this study, we investigate whether U.S. high-technology firms are more or less conditionally conservative relative to low-technology firms. If U.S. high-tech firms are required to expense immediately all R&D costs according to the accounting standard SFAS 2, which reflects unconditional...

This paper studies how pharmaceutical research and development (Ramp;D) investment responds to publicly supported biomedical research performed mainly in universities and non-profit institutions. New micro-level data on investment by the U.S. National Institutes of Health allow measures of...

The present paper evaluates the quantitative impact of a pharmaceutical reform on pharmaceutical prices. A generic substitution policy was introduced in Finland in 2003 to contain rising pharmaceutical expenditure. After the reform pharmacists were obliged to propose a cheaper alternative to a...

A panel of aggregate data for 50 provinces is used to analyze Spain's per capita public pharmaceutical expenditures. In contrast to previous practice, our approach permits the analysis of the effects determinants on pharmaceutical expenditure to be heterogeneous across years and provinces....

Corporate governance has received a lot of attention in India because of the scandals that have taken place in the corporate world in the last two decades. Investors are also concerned over the relationship between corporate governance and performance indicators. In this context, our study...

The Brazilian pharmaceutical industry has always been targeted by the society, due to the ethical drugs' high weight in the families' consumption budgets (especially within the poorer ones) and price raises traditionally above inflation (when the government does not run a price control). The...

New product launches are often accompanied by extensive marketing communication campaigns. Firms' allocation decisions for these marketing communication expenditures have two dimensions - across consumers and over time. This allocation problem is different relative to the problem of allocation...

This study analyses the impact of mergers and acquisitions on performance of Indian pharmaceutical firms following the implementation of TRIPS in 1995. In order to identify adequately the effect of mergers, we investigate the impact on firm performance of the merged vis-a-vis the non-merged...